DJ Gilead Sciences Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) slid 1.48% to $134.28 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.01% to 7,457.69 and Dow Jones Industrial Average falling 0.77% to 52,146.42.
The stock's fall snapped a two-day winning streak.
Gilead Sciences Inc. closed 14.63% short of its 52-week high of $157.29, which the company reached on February 11th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 1.23% to $253.04, Pfizer Inc. $(PFE)$ fell 0.36% to $25.05, and Abbott Laboratories $(ABT)$ rose 1.87% to $100.68.
Trading volume (6.9 M) remained 1.1 million below its 50-day average volume of 7.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 17, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 17, 2026 16:35 ET (20:35 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments